Furthermore, western blot for serum anti-ganglioside antibodies was highly positive for anti-GM2 IgM antibodies and borderline positive for anti-GM1 IgM antibodies, thus supporting the diagnosis of GBS. The gene discussed is CD40LG; the disease is Guillain-Barre syndrome.